STAT3 and non-small cell lung carcinoma: As IL-23 can mediate STAT3 and PI3K signaling pathways amongst others, it is perhaps possible that constitutive activated pathways seen in NSCLC patients harboring these mutations, may be at increased risk of several cross talk feedback mechanisms, further perpetuating an oncogene addiction state.